FDA's Loud And Clear Message: Engage With FDA Early And Formally - Food, Drugs, Healthcare, Life Sciences
On February 10, 2022, the U.S. Food and Drug Administration (FDA) held a public Oncologic Drugs Advisory Committee (ODAC) meeting to...
Stay updated with breaking news from Human Subject. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On February 10, 2022, the U.S. Food and Drug Administration (FDA) held a public Oncologic Drugs Advisory Committee (ODAC) meeting to...
A basis for additional customized training programs for expatriate EMS providers working in Bahrain
This Advisory provides an update on several recently issued US Food and Drug Administration (FDA or the Agency) draft guidance documents and advice addressing areas of increased attention.
These policies result from the desire of the East Stroudsburg University of Pennsylvania to comply with federal regulations requiring the establishment of such a board. More fundamentally, the policy stems from the University’s self-imposed commitment to safeguard privacy, the rights and welfare of human participants in all research under its sponsorship, and to serve as their protector on behalf of the community of persons of which the University is a part. Please visit the corresponding links to learn more about the I...
April 30, 2021 WSU research guidance during the COVID‑19 pandemic is found here: research.wsu.edu/covid-19/. WSU is currently in Stage 3 of the “Staged return to on‑site research, scholarship, and creative activities” guidance. The plan includes system‑wide efforts to assist researcher success during the COVID‑19 pandemic. For research involving human participants, see the “Staged Return to Human Subject Research” guidance. Other research guidance, including the “Monitoring and managing research compliance” document and “exception request”, can also be accessed.